Background
Nevus araneus, also known as spider angioma or spider nevus, is a common benign vascular lesion present in 10-15% of healthy adults and young children.[1, 2] They may appear as a solitary or multiple lesions.[2] In particular, when multiple lesions are present, liver disease, estrogen therapy, and thyrotoxicosis are worth considering. The name stems from its physical appearance, which is characterized by a central red arteriole, or punctum, representing the body of the spider, surrounded by a radial pattern of thin-walled capillaries, resembling legs (see the image below).
A spider nevus consists of a central arteriole with radiating thin-walled vessels. Compression of the central vessel produces blanching and temporarily obliterates the lesion. When released, the threadlike vessels quickly refill with blood from the central arteriole. The ascending central arteriole resembles a spider's body, and the radiating fine vessels resemble multiple spider legs. Nevus araneus lesions range in size from 1-10 mm in diameter. Compression of the central vessel with a slide (diascopy) results in blanching and temporary obliteration of the lesion, which is followed by rapid return of blood flow upon release.[1] Pulsations may occasionally be felt upon compression of the punctum.[3] In adults, spider angiomas (nevus araneus) are most frequently found on exposed areas of the body, such as the face, neck, upper trunk (above the nipple line), and arms. In children, the backs of the hands and fingers are commonly affected.[1, 3]
Pathophysiology
Vascular malformations can be classified into 6 categories: hamartomas, malformations, dilatations of preexisting vessels, hyperplasias, benign neoplasms, and malignant neoplasms.[3] Spider angiomas (nevus araneus) are not vascular proliferations; they occur as a result of the dilation of preexisting vessels.[1, 3]
While most lesions are unrelated to internal disease, spider angiomas (nevus araneus) have been associated with thyrotoxicosis,[4] and frequently occur in the presence of estrogen-excess states, such as pregnancy or during the use of oral contraceptives. Resolution of lesions in this context is common 6-9 months postpartum or after discontinuation of oral contraceptive medication.[5]
Spider angiomas (nevus araneus) are also associated with liver disease, liver failure, and cirrhosis.[6, 7, 8] In fact, the spider angioma is rumored to have received its name from barmaids in New York, who used the lesion as a marker of liver disease in customers.[4] When associated with liver disease, spider angiomas may be numerous, and other findings may be present, including palmar erythema, muscle atrophy, gynecomastia, ascites, jaundice, splenomegaly,[4] as well as nail findings such as leukonychia, onychomycosis, and longitudinal striations.[9] The number of lesions may be indicative of the extent of hepatic fibrosis.[8]
Epidemiology
Frequency
United States
Young children and pregnant women most frequently exhibit spider angioma (nevus araneus) lesions. In pregnant women, palmar erythema may also be present.[5] Spider angiomas are common in otherwise healthy children and are present in 10-15% of healthy adults and young children.[1]
International
The frequency of spider angiomas (nevus araneus) is presumed to be similar to that in the United States.
Mortality/Morbidity
Spider angiomas (nevus araneus) are asymptomatic benign lesions. When extensive, they may be associated with significant underlying internal pathology, such as liver disease.[6, 7, 8] Spider angiomas (nevus araneus) also may produce significant cosmetic concerns in some patients.
Although a finding of 5 or more spider nevi is common in children with liver disease, this quantity can also be present in many healthy children.[2]
Race
No racial predilection is reported for spider angioma (nevus araneus), but lesions are more apparent in light-skinned patients.
Sex
Spider angiomas (nevus araneus) are more common in women than in men, although a definitive study documenting this is not available. Young children of both sexes and pregnant women frequently exhibit lesions.[2, 5]
Age
One study demonstrated that 38% percent of healthy, school-aged children (ages 5-15 y) had at least one spider nevus (nevus araneus), while most had 1-4 lesions. The trend was an increasing number of lesions with increasing age.[2] Spider angiomas also are common in women of childbearing age in association with pregnancy or oral contraceptive use.[5]
Khasnis A, Gokula RM. Spider nevus. J Postgrad Med. Oct-Dec 2002;48(4):307-9. [Medline]. [Full Text].
Finn SM, Rowland M, Lawlor F, Kinsella W, Chan L, Byrne O, et al. The significance of cutaneous spider naevi in children. Arch Dis Child. Jul 2006;91(7):604-5. [Medline]. [Full Text].
Requena L, Sangueza OP. Cutaneous vascular anomalies. Part I. Hamartomas, malformations, and dilation of preexisting vessels. J Am Acad Dermatol. Oct 1997;37(4):523-49; quiz 549-52. [Medline]. [Full Text].
Graham-Brown RA. Hepatobiliary System and the Skin. In: Irwin Freedberg AE, Klaus Wolff, K Frank Austen, Lowell Goldsmith, Stephen Katz, Thomas Fitzpatric. Fitzpatrick's Dermatology In General Medicine. Fifth. New York: McGraw-Hill; 1999:1918.
Henry F, Quatresooz P, Valverde-Lopez JC, Piérard GE. Blood vessel changes during pregnancy: a review. Am J Clin Dermatol. 2006;7(1):65-9. [Medline]. [Full Text].
Detry O, De Roover A. Images in clinical medicine. Spider angiomas. N Engl J Med. Jan 15 2009;360(3):280. [Medline]. [Full Text].
Akiyama M, Inamoto N. Arteriovenous haemangioma in chronic liver disease: clinical and histopathological features of four cases. Br J Dermatol. Mar 2001;144(3):604-9. [Medline]. [Full Text].
Niederau C, Lange S, Frühauf M, Thiel A. Cutaneous signs of liver disease: value for prognosis of severe fibrosis and cirrhosis. Liver Int. May 2008;28(5):659-66. [Medline]. [Full Text].
Salem A, Gamil H, Hamed M, Galal S. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. Jun 2010;24(6):649-54. [Medline]. [Full Text].
Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol. Feb 1999;94(2):502-7. [Medline]. [Full Text].
Isner JM, Pieczek A, Schainfeld R, Blair R, Haley L, Asahara T, et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet. Aug 10 1996;348(9024):370-4. [Medline]. [Full Text].
Li CP, Lee FY, Hwang SJ, Lu RH, Lee WP, Chao Y, et al. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol. Dec 2003;9(12):2832-5. [Medline]. [Full Text].
Li CP, Lee FY, Hwang SJ, Chang FY, Lin HC, Lu RH, et al. Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol. May 1999;34(5):520-3. [Medline]. [Full Text].
Iino S. [Differentiation alcoholic liver cirrhosis from viral liver cirrhosis]. Nippon Rinsho. Jan 1994;52(1):174-80. [Medline].
Collyer J, Boone SL, White LE, Rademaker A, West DP, Anderson K. Comparison of treatment of cherry angiomata with pulsed-dye laser, potassium titanyl phosphate laser, and electrodesiccation: a randomized controlled trial. Arch Dermatol. Jan 2010;146(1):33-7. [Medline]. [Full Text].
Sivarajan V, Al Aissami M, Maclaren W, Mackay IR. Recurrence of spider naevi following treatment with 585 nm pulsed dye laser. J Plast Reconstr Aesthet Surg. 2007;60(6):668-71. [Medline]. [Full Text].
Clark C, Cameron H, Moseley H, Ferguson J, Ibbotson SH. Treatment of superficial cutaneous vascular lesions: experience with the KTP 532 nm laser. Lasers Med Sci. 2004;19(1):1-5. [Medline]. [Full Text].
Bjerring P, Christiansen K, Troilius A. Intense pulsed light source for treatment of facial telangiectasias. J Cosmet Laser Ther. Dec 2001;3(4):169-73. [Medline]. [Full Text].
Kono T, Sakurai H, Groff WF, Chan HH, Takeuchi M, Yamaki T, et al. Comparison study of a traditional pulsed dye laser versus a long-pulsed dye laser in the treatment of early childhood hemangiomas. Lasers Surg Med. Feb 2006;38(2):112-5. [Medline]. [Full Text].
Michel JL. Treatment of hemangiomas with 595 nm pulsed dye laser dermobeam. Eur J Dermatol. Mar-Apr 2003;13(2):136-41. [Medline].
Tan E, Vinciullo C. Pulsed dye laser treatment of spider telangiectasia. Australas J Dermatol. Feb 1997;38(1):22-5. [Medline]. [Full Text].
Tan OT, Gilchrest BA. Laser therapy for selected cutaneous vascular lesions in the pediatric population: a review. Pediatrics. Oct 1988;82(4):652-62. [Medline]. [Full Text].
Woo SH, Ahn HH, Kim SN, Kye YC. Treatment of vascular skin lesions with the variable-pulse 595 nm pulsed dye laser. Dermatol Surg. Jan 2006;32(1):41-8. [Medline]. [Full Text].

